NCT07552922 Determining INdividual Preferences for Gynecomastia avOidance (DINGO) - Stage 1
| NCT ID | NCT07552922 |
| Status | Recruiting |
| Phase | — |
| Sponsor | St Vincent's Hospital, Sydney |
| Condition | Prostate Cancer (Adenocarcinoma) |
| Study Type | INTERVENTIONAL |
| Enrollment | 24 participants |
| Start Date | 2025-12-01 |
| Primary Completion | 2026-05-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 24 participants in total. It began in 2025-12-01 with a primary completion date of 2026-05-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to explore the perceptions of men with prostate cancer (PCa) and high-risk biochemical recurrence (BCR) regarding the risk of breast-related side effects, including gynaecomastia, from treatment.
Eligibility Criteria
Inclusion Criteria: * Men with high-risk BCR PCa but no ADT+/-ARPI experience. * Men with ADT+/-ARPI experience who have experienced breast-related side effects from this treatment. Exclusion Criteria: • Men receiving psychiatric care as a consequence of their prostate cancer diagnosis or treatment thereof.
Frequently Asked Questions
Who can join the NCT07552922 clinical trial?
This trial is open to male participants only, aged 18 Years or older, studying Prostate Cancer (Adenocarcinoma). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07552922 currently recruiting?
Yes, NCT07552922 is actively recruiting participants. Visit ClinicalTrials.gov or contact St Vincent's Hospital, Sydney to inquire about joining.
Where is the NCT07552922 trial being conducted?
This trial is being conducted at Sydney, Australia.
Who is sponsoring the NCT07552922 clinical trial?
NCT07552922 is sponsored by St Vincent's Hospital, Sydney. The trial plans to enroll 24 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.